There is provided a fully human monoclonal antibody against human epidermal growth factor receptor (EGF-r) that possess similar or enhanced activities as compared to antibody C225 in order to vitiate concerns and/or effects of HAMA or HACA response. The antibody secreted by the hybridoma E2.11 comprises a human IgG2 antibody having a human kappa light chain.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.